Chronic HCV (CHC) carriers demonstrate elevated serum EV-associated CD81 levels, particularly pronounced in treatment-naive or persistently infected individuals, with expression positively correlating with hepatic injury markers (alanine aminotransferase [ALT]) and fibrosis staging. This evidence concerns the gene GPT and cryohydrocytosis.